TransThera Sciences (Nanjing) Inc banner
T

TransThera Sciences (Nanjing) Inc
HKEX:2617

Watchlist Manager
TransThera Sciences (Nanjing) Inc
HKEX:2617
Watchlist
Price: 59.7 HKD -1.08% Market Closed
Market Cap: HK$23.7B
No Transactions Found

We don't have any information about TransThera Sciences (Nanjing) Inc's insider trading.

Global
Insiders Monitor

TransThera Sciences (Nanjing) Inc
Glance View

Market Cap
23.7B HKD
Industry
Biotechnology

TransThera Sciences (Nanjing) Inc is a CN-based company operating in Biotechnology industry. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2025-06-23. TransThera Sciences (Nanjing) Inc is a China-based biopharmaceutical company principally focusing on discovering and developing innovative small molecule therapies for oncology, inflammatory and cardiometabolic diseases. The firm's core product Tinengotinib is a registrational clinical stage, internally discovered and developed, MTK inhibitor indicated for certain relapsed or refractory, drug-resistant solid tumors. The firm's oncology pipeline includes TT-00973 (against AXL), TT-01488 (for hematologic malignancies), TT-01688 (for inflammatory diseases) and TT-00920 (for chronic heart failure). The products are capable of being efficacious in a broad range of cancer types (including prostate cancer, HCC, breast cancer, and BTC). The company is also applied to cure hepatocellular carcinoma, breast cancer, biliary tract cancer and Pan-FGFR solid tumor.

Intrinsic Value
0.55 HKD
Overvaluation 99%
Intrinsic Value
Price HK$59.7
T

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett